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It has been shown that γδ T cells protect against the formation of
squamous cell carcinoma (SCC) in several models. However, the role
of γδ T cells in human papillomavirus (HPV)-associated uterine cervical
SCC, the third-leading cause of death by cancer in women, is un-
known. Here, we investigated the impact of γδ T cells in a transgenic
mouse model of carcinogenesis induced by HPV16 oncoproteins. Sur-
prisingly, γδ T cells promoted the development of HPV16 oncoprotein-
induced lesions. HPV16 oncoproteins induced a decrease in epidermal
Skint1 expression and the associated antitumor Vγ5+ γδ T cells, which
were replaced by γδ T-cell subsets (mainly Vγ6+ γδlowCCR2+CCR6−)
actively producing IL-17A. Consistent with a proangiogenic role, γδ
T cells promoted the formation of blood vessels in the dermis un-
derlying the HPV-induced lesions. In human cervical biopsies, IL-
17A+ γδ T cells could only be observed at the cancer stage (SCC),
where HPV oncoproteins are highly expressed, supporting the clinical
relevance of our observations in mice. Overall, our results suggest
that HPV16 oncoproteins induce a reorganization of the local
epithelial-associated γδ T-cell subpopulations, thereby promoting
angiogenesis and cancer development.
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Tcells bearing a γδ T-cell receptor (TCR) are unconventionalT cells that display adaptive features such as the formation of
a TCR by somatic recombination (like in αβ T cells) along with
innate characteristics, such as a rapid response independent of
professional antigen-presenting cells (1, 2). γδ T cells contribute to
immune responses to infection, cellular transformation and tissue
damage (2, 3). γδ T cells have well-established protective roles in
cancer, largely on the basis of their potent cytotoxicity and IFN-γ
production (3). Multiple studies in several mouse cancer models
have established the protective role of γδ T cells during tumor
development by comparing tumor progression in γδ T-cell–
deficient mice (via genetic inactivation of the TCRδ locus) (4)
versus γδ T-cell–sufficient mice [wild type (WT)] (5–8). In this
regard, γδ T cells protect against the development of squamous
cell carcinoma (SCC) (5, 9) and against transplanted B16 mela-
noma (6, 10). In line with these observations in mouse models, a
recent study analyzing the gene expression profiles of thousands of
samples derived from 39 different cancer types, including mela-
noma, revealed γδ T cells as the most significant favorable prog-
nostic immune population (11). Tumor cell recognition and
associated γδ T-cell activation have been attributed to engagement
of the TCR and/or natural killer receptors (NKRs), mostly
NKG2D (3). NKG2D is a crucial innate receptor in tumor sur-
veillance, as demonstrated by the high cancer susceptibility of
NKG2D-deficient mice. NKG2D is a sensor for molecular stress
signatures [such as the NKG2D ligand retinoic acid early inducible
1 (Rae1) in mice] that are largely absent from healthy cells but
often up-regulated by transformed cells (3).
In contrast to αβ T cells, γδ T cells are divided into subsets based
on the type of γ and/or δ chain they express within their TCR, which
are usually associated with particular organs and even particular
tissue locations within these organs. Thus, the murine skin Vγ5Vδ1
T cells, also known as dendritic epidermal T cells (DETCs), are
highly prevalent in the epidermis as intraepithelial lymphocytes,
while other subsets (expressing the Vγ4 or Vγ6 chain) are enriched
in the dermis (2, 12–15). The DETC TCRs are constitutively clus-
tered and functionally activated in vivo at steady state, forming true
immunological synapses that polarize and anchor T-cell projections
at squamous keratinocyte tight junctions (16). It has been shown
that Skint1, a member of the butyrophilin-like (Btnl) family of
proteins that is selectively expressed by keratinocytes in the epi-
dermis, drives the selective maturation of DETC progenitors.
DETC are >90% ablated in Skint1 mutant mice, while all other
T-cell populations are unaffected (17–19). More recently, a similar
mechanism has been revealed for the intraepithelial γδ T-cell rep-
ertoire of the gut, both in mouse and human (20). Thus, the usage
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of Btnl genes by epithelia appears to be a conserved mechanism
that shapes local T-cell compartments.
Human papillomavirus (HPV) is a DNA virus that infects
keratinocytes of the genital tract mucosa and the skin. Persistent
infection with high-risk HPV types may lead to cancers of the
anogenital region as well as of the head and neck (21). The world
health organization (www.who.int/mediacentre/factsheets/fs380/
en/, accessed October 17, 2016) classified uterine cervical cancer
as the second most common cancer in women living in less de-
veloped regions. This persistent infection with high-risk HPV is
associated with the overexpression of the HPV oncoproteins
E6 and E7 in nearly all epithelial cells (22, 23). The p53 and
retinoblastoma proteins are well-characterized targets of these
HPV oncoproteins but more recent studies have shown that the
alteration of additional pathways are also important for trans-
formation such as the DNA damage response pathway (24, 25).
For example, high-risk HPV E7 has been shown to activate the
ATM DNA damage response in keratinocytes (26), a pathway
that is implicated in the up-regulation of NKG2D ligands (27).
Besides the well-established protective role of γδ T cells against
cancer, more recent studies revealed also tumor-promoting activ-
ities, which are often related to the production of IL-17 (28–31).
On the other hand, IL-17–producing γδ T cells have been shown to
contribute to the anticancer effect of bacillus Calmette–Guerin
against bladder carcinoma and to the efficacy of anticancer che-
motherapy (32–34). The role of γδ T cells in HPV-induced ma-
lignancy is not known. Even in the aforementioned study analyzing
the prognostic value of immune cells across 39 tumors, uterine
cervical cancer samples were not included (11). Here, we in-
vestigated the role of γδ T cells in HPV-induced cancers in a
mouse model where the HPV16 early-region genes, including the
oncogenes E6 and E7, are specifically expressed in the keratino-
cytes leading to the formation of malignant SCC (35). We further
analyzed a series of biopsies of human HPV-associated squamous
intraepithelial lesions (SILs) and SCC. Altogether, our observa-
tions support the notion that HPV oncoprotein-induced remod-
eling of epithelial-associated γδ T-cell populations promotes the
cancerous development of HPV-associated lesions.
Results
γδ T Cells Promote the Formation of HPV-Induced Lesions. To address
whether γδ T cells play a pro- or antitumor role in HPV-associated
lesions, K14-HPV16 mice [a model for HPV-induced carcinogen-
esis (35), designated here as HPV mice] were crossed with mice
lacking γδ T cells (TCRδ−/−mice) (5). The spontaneous formation
of lesions on the skin, head, ears, and tail was followed from 6 to
36 wk of age in both HPV and HPV TCRδ−/− mice and scored as
described in SI Appendix, Fig. S1. Strikingly, the presence of γδ
T cells promoted the formation of HPV-induced lesions (Fig. 1).
At week 16, around 90% of HPV mice showed a lesion score
higher than 7, whereas only 10% of the HPV TCRδ−/− mice
reached this score (Fig. 1B). Thus, γδ T cells appear to favor the
development of HPV oncoprotein-induced skin lesions.
Skint1 Expression and Density of Resident Vγ5+ γδ T Cells (DETCs) Are
Reduced in Mice Expressing HPV Oncoproteins in Epidermis. DETCs,
the epidermal resident γδ T cells expressing the Vγ5 chain, have
been assigned antitumor functions (5, 36). To gain insight into the
unexpected protumor role of γδ T cells in the formation of epider-
mal lesion induced by HPV oncoproteins, we investigated the
DETCs in detail in HPV mice before the appearance of severe le-
sions. At weeks 6–8, the in vivo expression of HPV oncoproteins
within keratinocytes is associated with a very significant decrease of
Skint1 expression, the skin-specific Btnl member known to be crucial
for the presence of DETCs within the skin (17) (Fig. 2A). This de-
crease in Skint1 expression was independent of the presence of γδ
T cells (SI Appendix, Fig. S2A). We also assessed the effect of HPV
oncoproteins on the expression of the NKG2D ligand Rae1, as
DETCs, especially when activated, express high levels of NKG2D (5,
37). However, unlike Skint1, expression of epidermal Rae1 was not
significantly influenced by HPV oncoproteins (SI Appendix, Fig.
S2B). The decrease in Skint1 expression was associated with a clear
change in the morphology of the DETCs of HPV mice: they showed
a more round shape compared with the classical dendritic cell-like
morphology of DETCs in WT mice (Fig. 2 B and C). Furthermore,
quantification of the density of Vγ5+ cells within the epidermis by
confocal microcopy revealed a marked reduction in the Vγ5+ cell
density in HPV skin (Fig. 2 B and D). We observed similar results
when cell circularity and cell density were quantified for γδTCRhigh
T cells (SI Appendix, Fig. S2 C andD); indeed, high expression of the
γδ TCR on skin γδ T cells is known to be derived from
Vγ5 expressing γδ T cells (14). Thus, the expression of HPV
oncoproteins in keratinocytes causes a decrease of Skint1 expression,
which is associated with a reduction in the density of resident
antitumor DETCs.
HPV-Oncoprotein Expression in Epidermis Leads to Infiltration of Non-
Vγ5 γδ T Cells. Besides the observation via confocal microscopy
that the Vγ5+/TCRhigh cells were reduced in the epidermis of
HPV mice, there were indications for the presence of γδTCRlow
expressing γδ T cells and CD3+γδ− T cells (Fig. 2B, Inset arrows).
These preliminary observations were investigated further to as-
sess the possible infiltration of other γδ T cells in the epidermis
of HPV mice. By using flow cytometry, we showed a reduction in
the percentage of Vγ5+/γδTCRhigh cells in HPV epidermis,
which was accompanied by an increase in the percentage of
γδTCRlow expressing γδ T cells (Fig. 3 A and B). We observed
also an increase in the percentage of CD3+γδneg T cells in HPV
epidermis (Fig. 3A) and confirmed that these cells express an αβ
TCR (SI Appendix, Fig. S3), explaining the decrease in per-
centage of γδTCR+ cells within CD3+ cells (Fig. 3B). Besides the
percentage, also the absolute number of γδ TCRlow T cells in-
creased significantly in HPV epidermis (SI Appendix, Fig. S4A).
However, the absolute number of Vγ5+/γδTCRhigh cells did not
show a difference. The decrease in density observed by micros-
copy (Fig. 2D and SI Appendix, Fig. S2D) is thus likely due to the
fact that the epidermis of HPV mice is clearly thicker (SI Ap-
pendix, Fig. S4B) than in WT mice. Among the same line, the
decrease in percentage of Vγ5+/γδTCRhigh cells (among γδ
T cells) in HPV epidermis can be explained by the huge increase
in absolute numbers of γδTCRlow cells (SI Appendix, Fig. S4A).
In contrast to the epidermis, no changes in Vγ5+/γδTCRhigh or
γδTCRlow percentages (of total γδ T cells) could be observed in
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Fig. 1. γδ T cells accelerate the development of HPV-induced lesions in the
K14-HPV16 mouse model. (A) Ear lesion followup of four males from different
genetic backgrounds: WT, HPV, TCR δ−/−, and HPV TCR δ−/− at weeks 6, 8, 12,
and 16. (B) Percentage of HPV and HPVTCRδ−/−mice with a score >7 according
to age. HPV (n = 66, red line with squares) and HPV TCR δ−/− (n = 54, black line
with diamonds) mice were observed for 36 wk and assigned a lesion score
according to the severity of lesions present on their skin, head, ears, and tail. A
score >7 was considered as severe (logrank test, ***P < 0.001).
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the dermis (Fig. 3C). The lower expression of the γδ TCR within
HPV epidermis was not due to activated Vγ5+ DETCs reducing
their TCR levels upon activation, as these γδTCRlow γδ T cells
did not express the Vγ5 chain and are thus not DETCs (Fig. 3A).
While the Vγ5 chain could still be readily detected by flow
cytometry after dispase treatment (SI Appendix, Fig. S5A) to
separate the epidermis from the dermis, this was not the case for
Vγ4 (SI Appendix, Fig. S5B) and Vγ6 (SI Appendix, Fig. S5C), the
main Vγ chains used by dermal γδ T cells (12, 14, 15). Therefore,
we used qPCR to obtain further insight into the change in Vγ
usage of γδ T cells in the epidermis of HPVmice. The efficiency of
the different PCR reactions to quantify the different Vγ chains was
similar, allowing comparison of the qPCR data for the different Vγ
chains (SI Appendix, Fig. S6). We confirmed the decrease in Vγ5+
T-cell density observed by microscopy (Fig. 2D) in HPV epidermis
at the RNA level (Fig. 3D) and decreased Vγ5 RNA showed
correlation with lower Skint1 RNA expression (SI Appendix, Fig.
S2E). In parallel, the low level of Vγ5 mRNA expression was ac-
companied by a significant increase of Vγ6 mRNA (Fig. 3E). The
Vγ4 chain showed a tendency to be increased in HPV epidermis,
but this did not reach statistical difference; the other Vγ chains
showed very low expression and were not increased in HPV epi-
dermis (Fig. 3E). In sum, HPV-oncoprotein expression within the
epidermis leads to the epidermal infiltration of γδ TCRlow cells,
mainly expressing the Vγ6 chain. We call these cells from now
onwards “γδlow T cells.”
γδlow T Cells in HPV Epidermis Express High Levels of CCR2 but Reduced
Levels of CCR6. As the expression of HPV oncoproteins in the
keratinocytes of the epidermis leads to the recruitment of γδlow
T cells, we sought to obtain insight into the possible role of che-
mokine receptors and associated chemokine ligands. Since both
CCR2 (imiquimod model of psoriasis) (38) and CCR6 (IL-23 in-
jection model of psoriasis) (39) have been shown to be involved
into the recruitment of γδ T cells toward the skin, we focused on
these chemokine receptors and associated ligands. Furthermore,
CCR6 has been shown to be important for the homeostatic traf-
ficking of γδ T cells, including the Vγ6 subset, to the dermis (15,
40). The γδlow T cells in HPV epidermis showed high expression of
CCR2 (Fig. 4A). CCR2 expression was also increased on γδ T cells
derived from the dermis of HPV mice compared with WT mice
(Fig. 4B). In sharp contrast, CCR6 expression, which was highly
expressed on dermal γδ T cells of WT mice, showed marked re-
duced expression on HPV dermal γδ T cells and showed only low
expression on HPV epidermal γδlow T cells (Fig. 4 A and B). The
high expression of CCR2 on γδlow T cells in the HPV epidermis
was associated with an increased expression of the CCR2 ligand
CCL2 (the only CCR2 ligand that is not cross-reactive with other
chemokine receptors) (41, 42) in the HPV epidermis, while the
expression in the HPV dermis was decreased (Fig. 4C). Other
CCR2 ligands (CCL7 and CCL8), but not all (CCL12), showed
differential expression in epidermis and/or dermis of HPV mice (SI
Appendix, Fig. S7 A–C). In contrast, the unique ligand for CCR6,
CCL20, did not show differential expression (SI Appendix, Fig.
S7D). Thus, these data indicate that high CCR2 expression, to-
gether with reduced expression of CCR6 at the dermal niche, can
play an important role in the recruitment of γδlow T cells to the
epidermis upon HPV-oncoprotein expression.
γδlow T Cells Produce IL-17A in Epidermis of HPV Oncoprotein-Induced
Lesions. Recently, protumor roles of γδ T cells have been linked,
at least partially, to their capacity to produce IL-17 (28, 29, 31).
Therefore, we assessed whether our observations regarding a
protumor role of γδ T cells in HPV-induced lesions and the
corresponding reorganization of the epidermal γδ T cell subsets
could be linked to the production of IL-17A. Epidermal cell
suspensions from HPV mice contained more IL-17A mRNA
compared with WT mice (Fig. 5A), while no difference was ob-
served for IL-13, an antitumor cytokine recently detected in the
epidermal γδ T cells (43) (SI Appendix, Fig. S8A). By in-
vestigating this further at the protein level by flow cytometry, we
found that γδ T cells within epidermal cell suspensions derived
from HPV mice briefly cultured in vitro, without further stimu-
lation, clearly produced IL-17A, while epidermal γδ T cells from
WT mice did not (Fig. 5 B and C). This spontaneous IL-17A
production likely reflects ongoing cell activation in vivo by the
HPV keratinocytes. IL-17 production was restricted to γδTlow
T cells (Fig. 5 C and D). IL-17 production was further increased
upon incubation with the artificial polyclonal stimulation treat-
ment phorbol myristate acetate (PMA) and ionomycin (Fig. 5
B–D). We observed also IL-17A production by CD3+γδ− cells (Fig.
5D), which are presumably Th17 cells. It may be noted that the
epidermis of TCRδ−/− HPV mice also displayed increased IL-17A
mRNA levels (SI Appendix, Fig. S8B), possibly due to the reported
replacement of “normal” γδ DETCs by “replacement αβ DETCs”
(36). However, T cells derived from HPV TCRδ−/− HPV mice
did not show HPV-induced spontaneous IL-17 protein expression
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Fig. 2. Reduced Skint1 mRNA expression in HPV mouse epidermis is asso-
ciated with resident Vγ5 cell (DETCs) morphological and density changes.
(A) Skint1 mRNA expression was measured by qPCR in WT and HPV mouse
epidermis. (B) Confocal microscopy pictures of WT and HPV mouse epidermal
sheets using anti-Vγ5 antibody (green) (Left) or panγδ (red) and anti-CD3
(green) antibodies and DAPI for nuclei staining (blue) (Right). Arrows in-
dicate different γδTCR expression intensities: yellow, high intensity; orange,
low intensity; green, no γδTCR expression (representative images of three
independent experiments). (C and D) Using ImageJ software, confocal mi-
croscopy images of Vγ5 staining in mouse epidermis were used to quantify
cell circularity (C) and density (D) (6- to 7-wk-old mice, Mann–Whitney test,
mean + SEM, **P < 0.01, ***P < 0.005).
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and/or release (SI Appendix, Fig. S8C), possibly reflecting the need
for the correct (γδ) TCR specificities to functionally respond to the
HPV oncoprotein-induced changes. Indeed, also the local cancer
protection role is provided only by the “real” γδ DETCs and not by
replacement αβ DETCs in TCRδ−/− mice (36). Of note, the in-
crease in IL-17–producing T cells in HPV mice was specific for the
epidermis, as such an increase was not observed in dermis from the
same mice (SI Appendix, Fig. S8D). Overall, these data indicate that
γδlow T cells from the HPV epidermis produce IL-17A in situ upon
encountering HPV oncoprotein-transformed keratinocytes.
γδ T Cells Promote HPV Oncoprotein-Induced Angiogenesis in the Skin.
Since both HPV oncoproteins and IL-17 have been implicated in
angiogenesis (44–46), we investigated blood vessel density by
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immunohistochemistry in ear sections from WT, HPV, TCRδ−/−,
and HPV TCRδ−/− mice. In the presence of γδ T cells, the per-
centage of blood vessel density was highly increased at weeks 6–8 in
epidermis expressing HPV oncoproteins (Fig. 6). However, in HPV
TCRδ−/− mice, this increase was significantly reduced; indeed,
dermal blood vessel density reached levels similar to those in
mice without expression of the HPV oncoproteins. Thus, this
indicates that γδlow T cells producing locally IL-17A upon en-
countering HPV-transformed keratinocytes promote the forma-
tion of blood vessels in the underlying dermis.
Human Cervical SCC Contains IL-17A–Producing γδ T Cells. To in-
vestigate how our results in the murine K14-HPV16 model could
translate in human, we verified the presence of γδ T cells and
associated IL-17A production in human biopsies of uterine cervix
by immunohistochemistry. Biopsies from nonlesional tissue (nor-
mal exocervix, Exo), from preneoplastic lesions (SILs) and from
cancerous lesions (SCC) were compared. The number of γδ T cells
were significantly increased in HPV-associated SCC, but not in
SILs, compared with normal exocervix (Fig. 7A). This increase in
γδ T-cell number was not linked to a general increase of all T cells
in these samples (Fig. 7A), indicating a preferential γδ T-cell re-
sponse in SCC samples. On a selected number of samples, a more
detailed analysis was performed by dual immunostaining with pan-
γδ TCR and IL-17A antibodies. While in some subjects without
tumor, IL-17A+ cells could be detected in the epidermis and un-
derlying stroma (Fig. 7E and SI Appendix, Fig. S9), these IL-17A+
cells were not γδ T cells. However, in SCC biopsies, both in the
epidermis and underlying stroma, IL-17A–producing γδ T cells
were observed (Fig. 7C). Thus, it appears that IL-17A–producing
γδ T cells are present in more advanced stages of HPV-induced
tumoral lesions (SSC), while γδ T cells detected in normal cervix
and in preneoplastic lesions were negative for IL-17A. Overall,
the presence of IL-17A–producing γδ T cells in the epidermis
upon HPV-oncoprotein overexpression, which leads to cancer
development, appears to be a conserved feature in mice and
human patients.
Discussion
This study shows that γδ T cells play a protumor role in a mouse
model of HPV oncoprotein-induced cancer. Local HPV-oncoprotein
expression in the epidermis resulted in a disturbance of the
normal γδ T cell subset distribution within the skin and induced
the presence of IL-17A–producing γδlow T-cell subsets in the
epidermis, which was associated with increased blood vessel
formation in the underlying dermis.
γδ T cells were identified as the most significant favorable
prognostic immune population among 39 cancer types (11).
However, HPV-induced cancers were not included in this study,
despite its high prevalence, especially in developing countries
(47) having poor access to the prophylactic vaccine (48). Pre-
vious studies that have investigated the role of γδ T cells in
epidermis-related tumors have found a clear antitumor role of γδ
T cells. In a seminal paper, Girardi et al. (5) showed that mice
lacking γδ T cells are highly susceptible to multiple regimens of
cutaneous carcinogenesis leading to SCC, either via inoculation
of carcinoma cells (intradermal injection with the SCC line
PDV) or chemical carcinogenesis [either intradermal injection
with the carcinogen methylcholanthrene (MCA) or skin appli-
cations of dimethylbenz[a]anthracene (DMBA) and phorbol
ester (12-O-tetradecanoylphorbol; TPA), which induce and pro-
mote cutaneous malignancy, respectively]. Also inoculation with
the widely used B16 melanoma cell line resulted in increased
tumor development in γδ T-cell–deficient mice (6). This was
followed by other studies using FVB mice (same strain as the
HPV16 transgenic mice used in this study) (35), that are highly
susceptible to chemically induced SCC (49), where the DMBA +
TPA protocol of cutaneous malignancy was used as well. Again,
γδ T cells prevented both the chemically induced development of
papillomas and their progression into cutaneous SCC, whereas
αβ T cells seemed to promote tumor progression (9). Moreover,
in the same HPV transgenic oncogene model, CD4+ αβ T cells
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have been shown to slightly facilitate tumor development (50).
The antitumor role of γδ T cells is (at least partially) attributed
to DETCs, emphasizing local immunosurveillance by this resi-
dent epidermal γδ T-cell subset (36, 51). In addition, in a mouse
model of polyomavirus-induced tumors (polyomavirus is a small
DNA tumor virus that carries as well as a potent oncogene with
similar mechanisms of action than E6 and E7 from HPV), γδ
T cells played a protective role (52). Thus, our finding that γδ
T cells clearly promoted HPV oncoprotein-induced lesions was
highly unexpected.
The protumor role of γδ T cells that we observed may be related
to specific effects mediated by HPV oncoproteins. We found that
the local overexpression of these proteins in keratinocytes, the
natural host cells for HPV infection, led to a significant reduction
of Skint1 expression in the epidermis. Epidermal Skint1 expression
is crucial for the presence of DETCs in the skin epidermis and
DETC maturation and Skint1 constitutively engages DETCs (19,
20). Thus, HPV oncoprotein-induced down-regulation of Skint1
can provide an explanation for the change in DETC morphology
and for their reduction in density within the epidermis. DETCs
may play an antitumor role via killing of tumor cells (5) or, as
shown more recently in vivo, by tissue regulation of the epithelial
barrier via IL-13 (43). The reduction of a particular (protumor) γδ
T-cell subset from the epithelial barrier via the decreased expres-
sion of the corresponding Btnl member can provide a mechanism
to evade the γδ T-cell subset that normally would provide tumor
immunosurveillance at the epithelial barrier. In addition, Skint1
has been shown to suppress Sox13, Rorγ, and Bcl11b that are as-
sociated with γδ T cells producing IL-17A (19, 20). Thus, reduced
Skint1 expression could also allow other γδ T-cell subsets (γδlow
T cells) that produce IL-17A to enter the epidermis. γδ T-cell
subsets that normally reside in the dermis, such as the Vγ6+ γδ
T-cell subsets, are very motile cells in contrast to immobile DETCs
(13–15). In addition, the high CCR2 expression that we observed
on γδ T cells in HPV mice and the associated changes in the ex-
pression of its ligand CCL2, together with the significant reduction
of CCR6 on dermal γδ T cells, can play an important role in this
trafficking of γδ T cells from the dermis toward the HPV epidermis
upon epidermal HPV-oncoprotein expression. Indeed, it has been
recently shown that CCR2 drives recruitment of dermal γδ T cells
to inflamed tissues while down-regulation of CCR6 prevents their
sequestration into uninflamed dermis (40). Of note, in the
B16 melanoma model, the CCR2–CCL2 axis also plays an im-
portant role in the recruitment of γδ T cells, but in that model the
γδ T cells were not producing IL-17 and had an antitumor role
(10). We propose that in the HPV model dermis-derived γδlow
T cells entering the epidermis end up in a “nonnatural” environ-
ment and can become activated by HPV-transformed keratinocytes
to make IL-17A as revealed by the spontaneous ex vivo IL-17A
production from epidermal γδlow T cells of HPV mice.
HPV-oncoprotein expression resulted in the rounding of
DETCs, indicating that they are activated. Rounded DETCs are
also observed during wound healing, but DETCs are not reduced
in density in this context (53). In contrast, in mice with acute
expression of the NKG2D ligand Rae1 in keratinocytes, DETCs
become rounded and disappear (36). In epidermis with HPV-
oncoprotein expression, however, no up-regulation of Rae1 was
observed. Thus, it is more likely that reduction of Skint1, rather
than up-regulation of Rae1, contributes to the observed re-
organization of the epidermal-associated γδ T cells upon HPV-
oncoprotein expression.
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In a recent study the immunosuppressive role of IL-17A was
investigated in a mouse model where the HPV oncoprotein E7 was
expressed under a keratin 14 (K14) promoter in a C57BL/6J
background (54). Using a skin graft model, the authors demon-
strated that IL-17A in HPV16 E7 transgenic skin grafts (E7 being a
nonself antigen) inhibited effective host immune responses against
the graft but, in contrast to our HPV-transgenic tumor lesion
model, no role for γδ T cells could be demonstrated (54). The same
study also investigated IL-17 production in CD4+ and γδ T cells
from three patients with CIN3 stage of lesion, corresponding to
high-grade SILs, and found IL-17 production only in CD4+ T cells,
but not in γδ T cells (54). However, they did not investigate SCC
samples. Only at that stage, we could clearly identify the presence of
IL-17 producing γδ T cells, while these cells were absent in SILs.
Angiogenesis, the process of forming new blood vessels from
preexisting ones, has been identified as a crucial factor for cervical
cancer growth (55, 56). Of note, it has been shown that the
HPV16 oncoproteins E6 and E7, via degradation of p53 and in-
activation of retinoblastoma protein (pRB), respectively, result in
the up-regulation of vascular endothelial growth factor (VEGF) in
keratinocytes, promoting angiogenesis and tumor growth (44, 45).
Moreover, E6 appears to promote VEGF in a p53 independent
way (44). Also IL-17 can induce the expression of proangiogenic
factors, including VEGF, from stromal or tumor cells and it can
enhance VEGF-induced vascular endothelial cell growth (46, 57).
We have shown here that γδ T cells are necessary for increased
angiogenesis in the dermis of HPV16-E6/E7 oncogene transgenic
mice. This may be due to the dermal-derived γδlow T cells pro-
ducing IL-17A in the epidermis upon recognition of E6/E7-trans-
formed keratinocytes. This local IL-17A production may on one
hand further increase the expression of the E6/E7-induced VEGF,
and on the other hand, act synergistically with VEGF in the pro-
motion of the growth of vascular endothelial cells.
Several treatments are currently approved for HPV-associated
diseases. Imiquimod is used to treat early stage lesions such as genital
warts or vulvar preneoplasic lesions, but not uterine cervical cancer
(58). On the other hand, bevacizumab, a recombinant humanized
monoclonal anti-VEGF antibody, was recently approved for the
treatment of patients with metastatic, recurrent, or persistent cervical
SCCs (56). Our finding that IL-17A–producing γδ T cells can be
specifically found within biopsies of HPV-induced SCCs, together
with our data generated in the mouse HPV16-transgenic model as
described above, points toward a possible contribution of these cells
to the increased angiogenesis during SCC cancer development.
Targeting IL-17A (e.g., with the anti–IL-17A mAb secukinumab)
and/or γδ T cells in this setting may enhance the therapeutic efficacy
of bevacizumab. Imiquimod is an agonist Toll-like receptor 7, which
induces up-regulation of type I IFN and activation of dendritic cells
(59), and treatment of mouse skin with imiquimod is used as a
murine model for psoriasis. This drug treatment induces the re-
cruitment of γδ T-producing IL-17A (38, 60). Moreover, in human
psoriatic lesions γδ T cells secreting IL-17A have been observed (60,
61). Since our data indicate a protumor role of IL-17–producing
γδ T cells in HPV oncoprotein-induced cancer, new clinical trials
(62) using imiquimod in HPV-induced pathology context should take
into account this population of IL-17A+ γδ T cells.
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Materials and Methods
Animals. All mouse experiments were conducted in accordance with the
guidelines of the local ethical committee of the University of Liège (Belgium).
FVBn mice (designated as WT mice) were bred in-house. K14-HPV16 transgenic
FVB/n mice (designated as HPV mice) (35) were obtained from Jeffrey Arbeit,
Washington University, St. Louis, through the National Cancer Institute Mouse
Repository. TCRδ−/−mice in FVB/n background (5) were generously donated by
M. Girardi, Yale University, New Haven, CT, and bred in-house. To generate
K14-HPV16 mice deficient in γδ T cells, hemizygous K14-HPV16 mice were
crossed with TCRδ−/−mice and the K14-HPV16–expressing progeny backcrossed
with homozygous TCRδ−/−mice. All mice were used at 6–36wk of age and were
age matched for all experiments. To compare HPV-induced lesions develop-
ment between K14-HPV16 and K14-HPV16 TCRδ−/−mice a lesion scoring system
was established (SI Appendix, Fig. S1). A total score was assigned to mice cor-
responding to the sum of ear, skin, head, and tail/anus lesion appearance. A
total score >7 was considered as severe.
RNA Extraction and Real-Time Quantitative PCR. Epidermis RNA was extracted
with Direct-Zol (Zymo Research) according to the manufacturer’s protocol.
We confirmed the quantity of RNA with a NanoDrop. cDNA was synthesizes
with a RevertAid H Minus First-Strand cDNA Synthesis Kit (Thermo Scientific).
SYBR Green PCR was performed in duplicate to determine mRNA levels in Vγ
chains, Skint1, Rae1, and IL-17 and the mRNA levels were normalized to
reference genes (ubiquitin C, UBC, and TATA-box binding protein, TBP).
Primers are listed in (SI Appendix, Table S1).
Immunofluorescent Staining and Morphological Analysis. Epidermal sheets
were obtained from the ear skin as previously described (36, 53). Briefly, after
hair removal, dorsal and ventral halves were incubated in 0.5 M of ammo-
nium thiocyanate for 20 min at 37 °C. Epidermal sheets were separated from
the dermis, fixed in acetone, and stained with antibodies to detect CD3+, γδ+
, and Vγ5+ cells (antibodies are listed in SI Appendix, Table S2). DAPI (Thermo
Fisher) was used to visualize nuclei. The stained sheets were rinsed in PBS
and mounted on slides with Eukitt medium (Fluka Analytical). Images were
acquired with a confocal microscope (Leica SP5) and transformed into binary
pictures using ImageJ. γδ T-cell density and circularity were calculated using
ImageJ sofware.
Human uterine cervical biopsies presenting normal exocervix, squamous
intraepithelial lesions, or squamous cell carcinomawere stainedwith anti-pan
γδ and anti–IL-17A antibodies (SI Appendix, Table S3). Alexa Fluor 488 and
594 coupled with streptavidin were used to visualize positive cells with a
Leica SP5 confocal microscope. DAPI staining was used to visualize nuclei and
single and double positive cells were counted in the normal or lesional epidermis
and in the underlying stroma. For normal exocervix samples, the counting fields
(40× magnification) were limited to the epithelium and to the corresponding
underlying conjunctive tissue. Concerning samples with lesions (precancerous
and cancerous, previously characterized by an anatomopathologist), the count-
ing fields (40×magnification) were limited to the epithelium displaying cervical
lesion (precancerous or cancerous, respectively) and to the corresponding un-
derlying conjunctive tissue. Number of counting fields varied between samples
from four to eight.
Epidermal and Dermal Cell Suspensions for Flow Cytometry Analyses. Epider-
mal and dermal cells were prepared from the ear skin. After physical sepa-
ration, dorsal and ventral halves were incubated in 2.5 units/mL of dispase II
(Roche) for 1 h at 37 °C. Epidermal and dermal sheets were separated, cut
into small pieces using scissors, and further digested separately using colla-
genase type IV (1 mg/mL; Sigma) for 1 h at 37 °C. The resulting suspensions
were mechanically disrupted using 18-G needles and syringes. Cells were
collected through 70-μm cell strainer to be further analyzed by flow
cytometry (FACScanto II). To test the reactivity and sensitivity to dispase
treatment of different Vγ chain antibodies, we used whole skin prepared as
above but without first the separation of epidermal and dermal sheets. This
whole skin cell suspension was then treated or not with dispase. In addition
to whole skin suspension, we used cell suspension derived from the uterus,
known to be highly enriched for γδ T cells expressing the Vγ6 chain (12).
Before surface staining, cells were Fc blocked with anti-CD16/32 (SI Ap-
pendix, Table S2) for 10 min at 4 °C. Cells were stained 30 min at 4 °C with
antibodies (SI Appendix, Table S2). To exclude dead cells from the analysis,
we added Viability Dye eFluor 780 (eBioscience) before surface staining. For
Vγ6+ staining, we used a protocol that combines the GL3 (anti-TCRγδ) and
17D1 (anti-Vγ5/Vγ6) monoclonal antibodies (63). For intracellular cytokine
staining, cells were incubated 4 h at 37 °C in the presence of brefeldin A
(10 μg/mL; eBioscience) and with or without PMA (6.25 ng/mL; Sigma) and
ionomycine (3.3 μg/mL; Sigma). Perm/Fix (BD Biosciences) was used according
to the manufacturer instructions and cells were stained for IL-17A. Cells were
analyzed on a FACS Canto II (BD Biosciences). Data analysis was performed
using FlowJo, LLC with the gating strategy described in SI Appendix, Fig. S10.
Absolute cell numbers were obtained from total numbers of epidermal and
dermal cells.
Immunohistochemistry. Mouse ear tissue sections of 5 mm were deparaffi-
nized and rehydrated through graded xylene and alcohol series. The slides
were heated in target retrieval or EDTA buffers (Zytomed Systems) for an-
tigen retrieval in a pressure cooker for 11 min and incubated with anti-Von
Willebrand Factor (VWF) antibody (SI Appendix, Table S2) for 1 h at room
temperature after blocking nonspecific binding with protein block serum free
(Dako) for 10 min. Sections were then incubated with TSA system (Perkin-
Elmer) or with peroxidase-labeled polymer conjugated to goat anti-rabbit
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immunglobulins (Dako EnVision). Antibodies were visualized using dia-
minobenzidine (Dako). Pictures of complete ear sections stained with anti-
VWF were used to calculate the percentage of dermis occupied by blood
vessels as described in ref. 64. Briefly, after manual blind segmentation by
two independent observers, the blood vessel density of complete ear sec-
tions was calculated with ImageJ software.
Human cervical tissues (45 normal exocervix, 33 SIL samples, and 17 SCC
samples) were provided, in agreement with the local ethical committee
(ethical national number B707201112047), by the GIGA Biothèque, which
performed informed consent procedures. For pan-γδ staining, slides were
heated in a water bath for 45 min at 99 °C and treated with the CSA II kit
(Dako) and stained with mouse anti-human TCRγ constant chain antibody (SI
Appendix, Table S3). For CD3 staining, slides were heated in EDTA buffer for
antigen retrieval in a pressure cooker for 11 min. Sections were incubated
with polyclonal rabbit anti-human CD3 (SI Appendix, Table S3) for 1 h.
Universal LSAB II kit/HRP (Dako) was used to detect primary antibody. Pan-γδ
and CD3 staining were visualized using diaminobenzidine (Dako).
Statistical Analysis. Statistical analyses were performed using R (version 3.2.4)
and Prism (GraphPad Software) (65). Raw data were transformed where
needed and back transformed for graphical presentation. Respect of the
assumptions of normal distribution of residuals and homoscedasticity in
linear models was verified using diagnostic plots.
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